Cargando…

KRAS mutations in patients with colorectal cancer in Libya

Large prospective clinical trials have demonstrated that colorectal cancers (CRCs) with wild-type KRAS respond favorably to anti-epidermal growth factor receptor treatment, thus making mutational analysis obligatory prior to treatment. In our study, frozen CRC tissues from Libyan patients were analy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abudabous, Asma, Drah, Mustafa, Aldehmani, Mamdouh, Parker, Iqbal, Alqawi, Omar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375022/ https://www.ncbi.nlm.nih.gov/pubmed/34462653 http://dx.doi.org/10.3892/mco.2021.2359

Ejemplares similares

A need for the standardization of the pharmaceutical sector in Libya
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Novel KRAS Gene Mutations in Sporadic Colorectal Cancer
por: Naser, Walid M., et al.
Publicado: (2014)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
por: Tria, Simon Manuel, et al.
Publicado: (2023)

IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
por: ZANATTO, Renato Morato, et al.
Publicado: (2020)

Impact of KRAS Mutation on Survival Outcome of Patients With Metastatic Colorectal Cancer in Jordan
por: Alkader, Mohammad S, et al.
Publicado: (2023)

The establishment of ethical guidelines for biomedical research in Libya
por: Bugaighis, Iman, et al.
Publicado: (2016)

Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations
por: Yan, Hong, et al.
Publicado: (2023)

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
por: Radanova, Maria, et al.
Publicado: (2023)

KRAS mutational analysis for colorectal cancer: Application: Pharmacogenomic
por: Wang, Grace, et al.
Publicado: (2010)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
por: Arrington, Amanda K., et al.
Publicado: (2012)

BRAF V600E and Novel Somatic Mutations in Thyroid Cancer of Libyan Patients
por: Tounsi-Guettiti, Haifa, et al.
Publicado: (2022)

Rotavirus in children with diarrhea in Tripoli, Libya
por: Kalaf, Rasha Noori, et al.
Publicado: (2011)

Discovery of decreased ferroptosis in male colorectal cancer patients with KRAS mutations
por: Yan, Hong, et al.
Publicado: (2023)

Clinical features and KRAS mutation in colorectal cancer with bone metastasis
por: Park, Hyung Soon, et al.
Publicado: (2020)

The role of kras mutations and MSI status in diagnosis of colorectal cancer
por: Shemirani, Atena Irani, et al.
Publicado: (2011)

Targeting KRAS G12C mutations in colorectal cancer
por: Zhao, Ming-He, et al.
Publicado: (2022)

Impact of KRAS Mutations on Management of Colorectal Carcinoma
por: Sullivan, Kevin M., et al.
Publicado: (2011)

Impact of microsatellite status on chemotherapy for colorectal cancer patients with KRAS or BRAF mutation
por: Huang, Chi-Jung, et al.
Publicado: (2016)

Noncoding RNA Profile in Reovirus Treated KRAS-Mutated Colorectal Cancer Patients
por: Saperstein, Rafael, et al.
Publicado: (2023)

Different metastatic pattern according to the KRAS mutational status and site-specific discordance of KRAS status in patients with colorectal cancer
por: Kim, Mi-Jung, et al.
Publicado: (2012)

Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma
por: Palomba, Grazia, et al.
Publicado: (2016)

The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
por: Won, Daeyoun David, et al.
Publicado: (2017)

KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan
por: Awidi, Muhammad, et al.
Publicado: (2019)

Recent Updates on the Significance of KRAS Mutations in Colorectal Cancer Biology
por: László, Loretta, et al.
Publicado: (2021)

Characterization of rare transforming KRAS mutations in sporadic colorectal cancer
por: Tong, Joanna HM, et al.
Publicado: (2014)

The predictive value of KRAS and NRAS mutations in metastatic colorectal cancer
por: Eshraghi, Abbas, et al.
Publicado: (2020)

Spatial heterogeneity of KRAS mutations in colorectal cancers in northern France
por: Turpin, Anthony, et al.
Publicado: (2019)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

Molecular pathological epidemiology of colorectal cancer in Chinese patients with KRAS and BRAF mutations
por: Li, Wenbin, et al.
Publicado: (2015)

Oral health in Libya: addressing the future challenges
por: Peeran, Syed Wali, et al.
Publicado: (2014)

High tumor mutation burden indicates better prognosis in colorectal cancer patients with KRAS mutations
por: Wang, Jianlei, et al.
Publicado: (2022)

Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
por: Yokota, Tomoya
Publicado: (2012)

Spatiotemporal and molecular epidemiology of cutaneous leishmaniasis in Libya
por: Amro, Ahmad, et al.
Publicado: (2017)

Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer
por: OUNISSI, Donia, et al.
Publicado: (2021)

Mutational status of plasma exosomal KRAS predicts outcome in patients with metastatic colorectal cancer
por: Lucchetti, Donatella, et al.
Publicado: (2021)

KRAS Mutational Profiles among Colorectal Cancer Patients in the East Coast of Peninsular Malaysia
por: Hasbullah, Hidayati Husainy, et al.
Publicado: (2023)

A survey of pharmaceutical company representative interactions with doctors in Libya
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

Obesity in Libya: a review
por: Elmehdawi, Rafik R., et al.
Publicado: (2012)

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
por: Kim, Seung Tae, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_bs9me88fu00a5cilod3fsun965